Pharma Stocks Update: Novo Nordisk’s Ozempic Shines
This article delves into the possible market effects of Novo Nordisk's diabetes drug, Ozempic, and shows how stocks have been reacting in response.
Thursday 12 October 2023
McDonald’s
More Companies Ride the Wave of Sanctions
Over the past few weeks, many companies imposed sanctions on Russia in an effort to halt Russia’s military activities in Ukraine. Despite the losses incurred by these companies, on Tuesday, other major names in the field joined the wave of sanctions. How could this affect their stocks?
Wednesday 09 March 2022
Turning Inflation Lemons to Lemonade
The Federal Reserve’s preferred inflation measure rose to its highest in roughly 30 years and Chair Jerome Powell sees inflation continuing into 2022. What assets may benefit from rising inflation? Historically, energy and consumer shares have risen in a high-inflation environment.
Thursday 30 September 2021
Get more from Plus500
Expand Your Knowledge
Videos & Articles help you expand your trading knowledge.
Prepare Your Trades
Our Economic calendar helps you explore global market events.
Trade Without Surprises
Understand the full costs of your trades now for better expense management later.
This information is written by Plus500 Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Plus500 will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.
Cryptocurrency CFDs are not available to Retail Clients.
